首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 歐洲醫療市場中民營領域的角色
產業/市場分類
醫療設備 (3974)
內視鏡檢查設備 (113)
分子呈像/呈影劑 (29)
心血管設備 (244)
可拋式醫學設備 (83)
核子醫學 (75)
病患監測 (343)
眼科設備 (100)
傷口護理 (87)
超音波 (49)
齒科設備 (172)
導管 (198)
整形外科 (329)
醫學影像診斷 (399)
體外診斷設備 (387)
CT/MRI/X光 (142)
e保健 (309)
市場調查報告書

歐洲醫療市場中民營領域的角色

The Role of the Private Sector in the European Market

出版商 HBS Consulting
出版日期 2006年06月 商品編碼 40488
內容資訊 英文  
價格
US $ 4450 MS Word file by E-mail (Single User License)
US $ 4450 PDF by E-mail (Single User License)
US $ 4500 Hard Copy


歐洲醫療市場中民營領域的角色 是由出版商HBS Consulting在2006年06月所出版的。 這份英文市場調查報告書價格從美金4450起跳。

簡介

歐洲的民營醫療市場正成為醫療儀器供應業者的重要收入來源。在歐洲的民營醫療領域市場中醫療儀器製造業者所佔銷售的比例預計今後將增加,並且在 2015 年前達到 50% 左右。

專門調查分析醫療儀器、藥品、生物相關、新興商業等市場趨勢並提供相關資訊的 HBS Consulting (總公司:倫敦),針對歐洲醫療市場中民營領域的角色進行調查分析,並出版報告書 "The Role of the Private Sector in the European Market"

本報告書內容包括:歐洲的醫療體系模式解說等市場概述、歐洲各國市場中民營領域的角色、民營企業採購醫療儀器的流程、與美國模式的比較、針對新技術的因應等詳盡調查分析結果。內容綱要摘記如下:

第1章 實施概要

第2章 概述

  • 歐洲的醫療系統模式
  • 資金籌措的困難
  • 醫療服務及技術成本的增加趨勢
  • 私人醫療保險的增加
  • 醫療技術(儀器)/醫療相關企業的角色

第3章 主要歐洲市場中民營領域的角色

  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 英國
  • 匈牙利

第4章 民營企業採購醫療儀器

  • 主要決策者
  • 影響採購決定的因素
  • 採購機制
  • 團體採購
  • 德國的經驗
  • 銷售 & 行銷策略
  • 租賃

第5章 美國的模式:借鏡歐洲

  • 美國的醫療系統
  • 美國 vs 歐洲:醫療儀器的影響
  • 從美國模式獲得的教訓

第6章 民營領域與醫療技術(儀器)的發展

  • 因應新技術(儀器)
  • 技術創新資訊的來源
  • 民營領域採用時的障礙
  • HTA 的影響
  • 民營領域中最平常的流程
  • 最新診斷技術之採用
  • 個案研究

第7章 總論

用語

目錄

Abstract

This latest strategic publication from HBS Consulting provides an overview of the changes taking place in the European private healthcare sector which will have a bearing on development of business and marketing strategies of medical devices and diagnostic manufactures. The report,

  • examines the trends in private healthcare provision and financing in key EU markets. Additionally, the two largest of the new EU member states - Hungary and Poland - are included
  • provides an overview of the main corporate players in the respective European markets
  • highlights some of the challenges and opportunities for manufacturers of medical devices and diagnostics in the emerging private healthcare sector
  • assesses some of the lessons which might be learned from studying the US model for healthcare provision

Table of Contents

1 EXECUTIVE SUMMARY

2 INTRODUCTION

  • 2.1 Models of Healthcare Systems in Europe
    • 2.1.1 Role of Private Medical Insurance
    • 2.1.2 Role of Private Providers
      • 2.1.2.1 Leading Providers
  • 2.2 The Funding Conundrum
    • 2.2.1 The Dutch Model
  • 2.3 Escalating Costs of Healthcare Services and Technology
  • 2.4 Private Medical Insurance Increasing
  • 2.5 Role of MedTech/Healthcare Companies in Healthcare Provision

3 THE PRIVATE SECTOR'S ROLE IN KEY EU MARKETS

  • 3.1 FRANCE
    • 3.1.1 French Health System and the Private Sector
    • 3.1.2 Private Providers
    • 3.1.3 Private Medical Insurance
    • 3.1.4 Market Dynamics
  • 3.2 GERMANY
    • 3.2.1 German Health System & the Private Sector
    • 3.2.2 Private Providers
    • 3.2.3 Private Medical Insurance
    • 3.2.4 Market Dynamics
  • 3.3 ITALY
    • 3.3.1 Italian Health System and the Private Sector
    • 3.3.2 Private Providers
    • 3.3.3 Private Medical Insurance
    • 3.3.4 Market Dynamics
  • 3.4 SPAIN
    • 3.4.1 Spanish Health System & the Private Sector
    • 3.4.2 Private Providers
    • 3.4.3 Private Medical Insurance
    • 3.4.4 Market Dynamics
  • 3.5 UK
    • 3.5.1 UK Health System and the Private Sector
    • 3.5.2 Private Providers
    • 3.5.3 Private Medical Insurance
    • 3.5.4 Market Dynamics
  • 3.6 Focus on Major New EU Markets
    • 3.6.1 HUNGARY
      • 3.6.1.1 Hungarian Health System and the Private Sector
      • 3.6.1.2 Private Providers
      • 3.6.1.3 Private Medical Insurance
      • 3.6.1.4 Market Dynamics
    • 3.6.2 POLAND
      • 3.6.2.1 Polish Health System and the Private Sector
      • 3.6.2.2 Private Providers
      • 3.6.2.3 Private Medical Insurance
      • 3.6.2.4 Market Dynamics

4 MEDTECH PURCHASING BY PRIVATE PURCHASERS

  • 4.1 Key Decision-Makers
  • 4.2 Factors Influencing Purchasing Decisions
  • 4.3 Purchasing Mechanisms
  • 4.4 Group Purchasing
    • 4.4.1 The German Experience
  • 4.5 Sales & Marketing Strategies
  • 4.6 Leasing

5 THE US MODEL: LESSONS FOR EUROPE

  • 5.1 US Healthcare System
    • 5.1.2 Sources of Healthcare Funding
    • 5.1.3 Private Healthcare Insurance
      • 5.1.3.1 Managed Care
      • 5.1.3.2 Trends in Employer-Sponsored Health Insurance
      • 5.1.3.3 Individual Health Insurance
    • 5.1.4 Universal Access Remains Elusive
  • 5.2 The US vs Europe: Impact on MedTech
  • 5.3 Learning from the US Model
    • 5.3.1 GPOs: The US Experience
      • 5.3.1.1 GPOs: Lessons for Europe
    • 5.3.2 Managed Care
      • 5.3.2.1 The UK Experience
        • 5.3.2.1.1 The Kaiser Model
        • 5.3.2.1.2 The Evercare Programme
    • 5.3.3 Health Technology Assessment
      • 5.3.3.1 Key Lessons

6 THE PRIVATE SECTOR AND MEDTECH INNOVATION

  • 6.1 Attitudes to New Technology
  • 6.2 Sources of Information on Innovation
  • 6.3 Barriers to Adoption by Private Sector
  • 6.4 Approving New Medical Technology
  • 6.5 Influence of HTA
  • 6.6 Procedures Most Commonly Performed in Private Settings
  • 6.7 Uptake of Diagnostic Innovation in Private Sector
    • 6.7.1 Case Studies

7 CONCLUSIONS

  • 7.1 Public Policies are Driving Private Healthcare
  • 7.2 Sales & Marketing Must Adapt to Purchasing Policies
  • 7.3 Private Sector Offers Opportunities for Innovation

GLOSSARY

Back to Top